|
Roth, B L; Meltzer, H Y; Khan, N (1998) Binding of typical and atypical antipsychotic drugs to multiple neurotransmitter receptors. Adv Pharmacol 42:482-5
|
|
Roth, B L; Willins, D L; Kristiansen, K et al. (1998) 5-Hydroxytryptamine2-family receptors (5-hydroxytryptamine2A, 5-hydroxytryptamine2B, 5-hydroxytryptamine2C): where structure meets function. Pharmacol Ther 79:231-57
|
|
Roth, B L; Choudhary, M S; Khan, N et al. (1997) High-affinity agonist binding is not sufficient for agonist efficacy at 5-hydroxytryptamine2A receptors: evidence in favor of a modified ternary complex model. J Pharmacol Exp Ther 280:576-83
|
|
Roth, B L; Shoham, M; Choudhary, M S et al. (1997) Identification of conserved aromatic residues essential for agonist binding and second messenger production at 5-hydroxytryptamine2A receptors. Mol Pharmacol 52:259-66
|
|
Palvimaki, E P; Roth, B L; Majasuo, H et al. (1996) Interactions of selective serotonin reuptake inhibitors with the serotonin 5-HT2c receptor. Psychopharmacology (Berl) 126:234-40
|
|
Berry, S A; Shah, M C; Khan, N et al. (1996) Rapid agonist-induced internalization of the 5-hydroxytryptamine2A receptor occurs via the endosome pathway in vitro. Mol Pharmacol 50:306-13
|
|
Choudhary, M S; Sachs, N; Uluer, A et al. (1995) Differential ergoline and ergopeptine binding to 5-hydroxytryptamine2A receptors: ergolines require an aromatic residue at position 340 for high affinity binding. Mol Pharmacol 47:450-7
|
|
Roth, B L; Tandra, S; Burgess, L H et al. (1995) D4 dopamine receptor binding affinity does not distinguish between typical and atypical antipsychotic drugs. Psychopharmacology (Berl) 120:365-8
|
|
Roth, B L; Palvimaki, E P; Berry, S et al. (1995) 5-Hydroxytryptamine2A (5-HT2A) receptor desensitization can occur without down-regulation. J Pharmacol Exp Ther 275:1638-46
|
